-
Pharma and Biotech Industry Outlook - Nov. 2010 - Industry Outlook
Tuesday, November 9, 2010 - 6:03pm | 2712With 2010 coming to an end, the pharmaceutical industry continues to witness major challenges like sluggish prescription trends, EU pricing pressure, intensifying generic competition and limited late-stage catalysts. The next five years are expected to reflect a significant imbalance between new...
-
WuXi PharmaTech Announces Third-Quarter EPS of $.30
Tuesday, November 9, 2010 - 5:54pm | 215WuXi PharmaTech Inc. (NYSE: WX) today announced its financial results for third-quarter 2010. Third-Quarter 2010 Highlights Net revenues grew 20% year over year to $83.8 million China-based Laboratory Services net revenues grew 19% year over year to $57.1 million U.S.-based Laboratory...
-
Bearish MACD for Techne Corp - Tale of the Tape
Tuesday, November 9, 2010 - 11:33am | 115Techne Corporation's (TECH) MACD indicator has moved into bearish territory with a reading of -0.3239. The Zacks #4 Rank (“Sell”) stock decreased slightly to $60.27 in the morning trade. The Zacks Consensus Estimate on the company's earnings for the year ending June 2011 has decreased by 5 cents...
-
Updated Model for Thermo Fisher Scientific Inc.
Tuesday, November 9, 2010 - 11:07am | 62Goldman Sachs released its updating model for 10Q yesterday on Thermo Fisher Scientific Inc. (NYSE: TMO). Goldman Sachs did not make changes to their investment thesis, rating, or price target. They did update their estimates but did not view those changes as material. TMO's price target is set at...
-
Kendle Posts First Sequential Rev. Growth In Over Two Years, Jefferies & Company Reports
Tuesday, November 9, 2010 - 9:50am | 74Kendle International (NASDAQ: KNDL) posted its first sequential revenue growth in over two years, Jefferies & Company reports. Net new wins also improved to $121MM, the highest level since 4Q08. “Kendle reported EPS of $0.10 on $83.2MM in revenue,” Jefferies & Company writes. “This was...
-
Kendle's 3Q EPS Beats Estimates
Tuesday, November 9, 2010 - 9:41am | 214Goldman Sachs has published a research report on Kendle International Inc. (NASDAQ: KNDL) after the company reported a 3Q that was aided to the upside by lower taxes. In the report, Goldman Sachs writes "Kendle reported 3Q EPS of $0.10, vs. us/consensus at $0.07/$0.04, helped by lower tax ($0.05 vs...
-
Benzinga's Top Pre-Market NASDAQ Losers (SNTS, CSKI, CHBT, QGEN)
Tuesday, November 9, 2010 - 9:36am | 131Santarus Inc (NASDAQ: SNTS) dipped 13.64% to $2.85 in the pre-market session. SNTS reported wider-than-expected Q3 loss. China Sky One Medical Inc (NASDAQ: CSKI) lost 12.23% to $8.68 in the pre-market session. CSKI posted a 16.3% y/y decline in its Q3 total revenue. China-Biotics Inc (NASDAQ: CHBT...
-
Illumina Inc (ILMN) Maintains Buy Rating
Tuesday, November 9, 2010 - 8:54am | 62Goldman Sachs published its research report on Illumina Inc (NASDAQGS: ILMN) this morning in which they maintain a Buy rating. Analysts note a lack of "material changes" as to why there are no changes in the investment thesis, rating, or price target. Goldman Sachs set the price target at $65.00....
-
Mad Money Lightning Round: Cramer Likes Honeywell (HON, JAZZ, ICLR, ANDE, DE, TSCO, STD, FCS, BIDU, GOOG, NAT)
Tuesday, November 9, 2010 - 4:36am | 324On CNBC's Mad Money, Jim Cramer said during the Lightning Round that Honeywell (NYSE: HON) is “terrific. Their CEO is in India promoting world trade. That stock goes much higher." For Jazz Pharmaceuticals (NASDAQ: JAZZ), he said, "That's had such a run I can't recommend it. That one's gone way too...
-
Kendle International Up 7.3% After Hours (KNDL)
Monday, November 8, 2010 - 7:32pm | 223Kendle International Inc. (Nasdaq: KNDL) released financial results after the market closed on Monday. Kendle International Inc reported that its 3rd quarter net income fell to $1.5 million, or 10 cents per share, down from $8.8 million, or 59 cents per share, a year earlier. The company's net...
-
Kendle Announces Third Quarter EPS of $.10
Monday, November 8, 2010 - 5:49pm | 161Kendle (Nasdaq: KNDL) today reported new business awards for the third quarter of 2010 of $131.4 million. Contract cancellations and related adjustments during the quarter moderated significantly to $10.4 million or 1.3 percent of the Company's backlog at June 30, 2010, resulting in a net book-to-...
-
SDIX Reports Third Quarter EPS of $0.00
Monday, November 8, 2010 - 5:11pm | 118SDIX (Nasdaq: SDIX) today reported financial results for the third quarter of 2010. Revenues for the quarter ended September 30, 2010 were $7.5 million, compared to $7.2 million for the same period in 2009. Year-to-date revenues were $21.0 million, which was equivalent to the same period in 2009....
-
Luminex Misses on All Fronts - Analyst Blog
Monday, November 8, 2010 - 2:03pm | 467Luminex Corporation (LMNX) reported third-quarter fiscal 2010 adjusted (excluding one-time items) loss per share of 2 cents, falling behind the Zacks Consensus Estimate of earnings of 4 cents per share. The results represent an improvement compared to the year-ago adjusted loss of 4 cents per...
-
Hapoalim Securities Adjusts Medivation Estimates
Monday, November 8, 2010 - 11:06am | 138Medivation, Inc. (NASDAQ: MDVN) expects to release top-line data from the Phase 3 HORIZON trial, evaluating dimebon's potential benefits in 403 patients with Huntington disease, in 1H11, Hapoalim Securities reports. “Based on dimebon's lack of efficacy in Alzheimer's, we remain skeptical that the...
-
Earnings Scheduled For November 8 (FTR, LDK, PCLN, SYY, CCO, MDR, QGEN, APEI)
Monday, November 8, 2010 - 4:31am | 209Frontier Communications (NYSE: FTR) is expected to report its Q3 EPS at $0.10 on revenue of $1.41 billion. LDK Solar Co Ltd (NYSE: LDK) is likely to report its Q3 EPS at $0.43. Priceline.com (NASDAQ: PCLN) is forecast to post its Q3 earnings at $4.97 per share on revenue of $974 million. Sysco Corp...